Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
Marco Canepa(Ospedale Policlinico San Martino), Marème Konté(Maria Cecilia Hospital), O. Amir, M. Hassanein(European Society of Cardiology), M. Otljanska, Cândida Fonseca, E. Fazlibegovic(Guglielmo da Saliceto Hospital), María G. Crespo‐Leiro(Complexo Hospitalario Universitario A Coruña), Luigi Tavazzi(Maria Cecilia Hospital), Edoardo Fiorucci(European Society of Cardiology), F.M. Fruhwald(European Society of Cardiology), Elin Folkesson Lefrancq(European Society of Cardiology), A. Temizhan(European Society of Cardiology), Andrew J.S. Coats(The Heart Research Institute), Marco Metra(Vita-Salute San Raffaele University), J Hradec(Apple (Israel)), M Lainscak(University of Ljubljana), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Elizabeta Srbinovska Kostovska(Maria Cecilia Hospital), G. Filippatos, Maryna Andarala(European Society of Cardiology), G. Gracia(Ospedale Policlinico San Martino), Petar Seferović, Ulf Dahlström(Linköping University), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Massimo Piepoli(University of Milan), Aldo P. Maggioni(Health Care Foundation), D. Logeart(European Society of Cardiology), Myriam Glémot(European Society of Cardiology), Teresa Ferreira(Centre for Human Genetics), Roberto Ferrari(University of Ferrara), Stefan D. Anker(Bayer (Germany)), Cécile Laroche(European Society of Cardiology), A. Kavoliuniene(Ospedale Policlinico San Martino)
Cited by 156
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k